t:slim X2 Insulin Pump with Control-IQ
Device Endocrinology
PDI 00850006613229
General payments
$5,076,521
Research payments
$8,817,385
Through program year 2025, $5,076,521 in general payments and $8,817,385 in research payments were reported against t:slim X2 Insulin Pump with Control-IQ (Endocrinology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
8 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,517,063 | 13,278 |
| 2025 | Research | $1,168,819 | 7 |
| 2024 | General | $1,383,014 | 9,526 |
| 2024 | Research | $4,699,226 | 33 |
| 2023 | General | $1,031,210 | 7,559 |
| 2023 | Research | $2,058,777 | 53 |
| 2022 | General | $1,145,233 | 6,197 |
| 2022 | Research | $890,563 | 21 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 113 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
36,560 general · 114 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.